Strategic Move: Enlivex Allocates $21 Million for RAIN Token Acquisition Amid Share Buyback
In a significant development for both biotechnology and cryptocurrency sectors, Nasdaq-listed Enlivex Therapeutics Ltd. has announced a substantial $21 million allocation to purchase.